Longwood Healthcare Leaders meeting, April 5-6, 2021, centered on MIT’s Koch Institute via web conference with leading biopharma CEOs, heads of R&D, top academic researchers, and healthcare investors, co-hosted by Nobel laureate and Biogen/Alnylam co-founder Phil Sharp. Speakers include Operation Warp Speed Chief Advisor Moncef Slaoui, FDA CDER Director Janet Woodcock, Genentech CEO Alexander Hardy, Johnson & Johnson Global R&D head Mathai Mammen, Sanofi R&D head John Reed, Takeda R&D head Andy Plump, AbbVie Chief Strategy Officer Henry Gosebruch, GSK Boston biotech head Mary Lynne Hedley, Merck Chief Patient Officer and former CDC Director Julie Gerberding, BMS R&D head Rupert Vessey, Alexion R&D head John Orloff, AbbVie R&D head Tom Hudson, Amgen R&D head David Reese, among others.
